FHA
KERX

Flagship Harbor Advisors’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Flagship Harbor Advisors’s Portfolio KERX Stock Details KERX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1,250
Closed -$4K – 2209
2018
Q3 		$4K Sell
1,250
-749
-37% -$2.7K ﹤0.01% 1794
2018
Q2 		$7K Buy
+1,999
New +$9.73K ﹤0.01% 1557

Flagship Harbor Advisors's KERX Position: Q4 2018 in Review

Flagship Harbor Advisors sold out of Keryx Biopharmaceuticals Inc (KERX) in Q4 2018, closing a stake of 1,250 shares — an estimated $4K sold.

Flagship Harbor Advisors first reported a position in KERX in Q2 2018 and held it in 2 quarters. The position peaked at $7K in Q2 2018. 1 fund tracked by Wall St. Rank holds KERX as of Q4 2018.

  • Flagship Harbor Advisors reported no remaining Keryx Biopharmaceuticals Inc position as of Q4 2018 after selling out during the quarter.
  • Flagship Harbor Advisors sold 1,250 Keryx Biopharmaceuticals Inc shares in Q4 2018, an estimated $4K.
  • Flagship Harbor Advisors first reported a position in Keryx Biopharmaceuticals Inc in Q2 2018 and held it in 2 quarters.
  • Flagship Harbor Advisors's Keryx Biopharmaceuticals Inc position peaked at $7K in Q2 2018.
  • 1 fund tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q4 2018.

Based on Flagship Harbor Advisors's 13F filing for Q4 2018, filed 28 Jan 2019.